NKY Global Precision Medicine R&D and Production Site is located at Songjiang District, a beautiful surburbs area and so-called Root of Shanghai. The site covers 56 hectors, while total built up area will be 120,000 square meters. As part of the G60 Science & Technology Innovation Valley, the site will benefit from convenient transportation lines and well developed industry chain.
NKY’s site has been recognized as a High-End Industrial Project by Shanghai government. NKY’s core business includes production and sales of IVD devices and kits, Companion Diagnostic services. NKY plans to invest 1.6 billion RMB in the next few years for this new site. The well-equipped new site will upgrade NKY’s R&D, production, sale & marketing activities.
The new site will be an important part of China’s emerging biopharma industry. NKY has invested in Huadao Biopharma and Immunotech Biopharm Ltd, two of China’s leading Biopharm companies in China. Huadao will use Builing 2 of the site to locate its own IP based CAR-T Whole Industry Chain; Immunotech will cooperate with NKY to develop Companion Diagnostics services for its immunotherapeutic drugs.